StonvexLoading…
StonvexStonvexStonvexCore line items from PRPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $6.77M | $34.98M | $122.65M | $79.04M |
Operating Income | $-38.63M | $-21.22M | $23.59M | $9.80M |
Net Income | $-53.36M | $-16.78M | $18.46M | $6.27M |
EPS (Diluted) | $-2.61 | $-0.98 | $1.02 | $0.40 |
Total Assets | $63.20M | $91.93M | $87.65M | $89.30M |
Total Liabilities | $55.85M | $42.54M | $24.02M | $30.67M |
Cash & Equivalents | $678.00K | $1.61M | $9.11M | $8.41M |
Free Cash Flow OCF − CapEx | $-18.44M | $-13.97M | $24.63M | $-17.85M |
Shares Outstanding | 29.87M | 18.05M | 16.21M | 15.49M |